deltatrials
Active Not Recruiting PHASE3 INTERVENTIONAL 2-arm NCT03949283

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

Standard Chemotherapy Versus Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

Sponsor: Cordgenics, LLC

Conditions Platinum-resistant Ovarian Cancer Recurrent Ovarian Carcinoma
Interventions ChemoID Assay Standard Chemotherapy
Updated 16 times since 2019 Last updated: Aug 20, 2024 Started: Jul 26, 2019 Primary completion: Jun 30, 2024 Completion: Dec 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03949283, this PHASE3 trial focuses on Platinum-resistant Ovarian Cancer and Recurrent Ovarian Carcinoma and remains ongoing. Sponsored by Cordgenics, LLC, it has been updated 16 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Jul 2020 · 4 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Nov 2021 · 6 months · monthly snapshot~Nov 2021 – ~Mar 2023 · 16 months · monthly snapshot~Mar 2023 – ~Sep 2023 · 6 months · monthly snapshot~Sep 2023 – ~Feb 2024 · 5 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Active Not Recruiting PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

  3. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  4. Sep 2023 — Feb 2024 [monthly]

    Recruiting PHASE3

  5. Mar 2023 — Sep 2023 [monthly]

    Recruiting PHASE3

▶ Show 11 earlier versions

  1. Nov 2021 — Mar 2023 [monthly]

    Recruiting PHASE3

  2. May 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

  3. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE3

  4. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  5. Mar 2020 — Jul 2020 [monthly]

    Recruiting PHASE3

  6. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE3

  7. Dec 2019 — Feb 2020 [monthly]

    Recruiting PHASE3

  8. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE3

  9. Sep 2019 — Nov 2019 [monthly]

    Recruiting PHASE3

  10. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  11. Jun 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cordgenics, LLC
Data source: Cordgenics, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations